GEMI vs RMD · rev $179.6M vs P/E 29, rev $5.65B
Gemini Space Station, Inc. Class A Common Stock (GEMI) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Gemini Space Station, Inc. Class A Common Stock (GEMI) is a capital markets company listed on NASDAQ.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported GEMI revenue for 2025-12-31 was $179.6M. Net income was -$582.8M. Revenue was up 26.3% from 2024-12-31 to 2025-12-31. GEMI currently screens at market cap $630.9M.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
GEMI currently screens at market cap $630.9M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the GEMI and RMD stock pages for the full models.
Not investment advice.